Our lawyers are actively pursuing Camp Lejeune water contamination lawsuits on behalf of individuals who resided, worked, or were otherwise exposed to the contaminated water at Marine Corps Base Camp Lejeune in North Carolina between August 1, 1953, and December 31, 1987, and subsequently developed certain health conditions.
For over three decades, the water supply at Camp Lejeune was contaminated with harmful chemicals, primarily trichloroethylene (TCE) and perchloroethylene (PCE), as well as benzene and vinyl chloride. These contaminants originated from various sources, including an off-base dry-cleaning facility and industrial activities on the base. Military officials were aware of the contamination as early as the 1980s but failed to take adequate steps to address the issue in a timely manner.
You may be eligible to file a Camp Lejeune lawsuit if you meet the following criteria:
The Camp Lejeune Justice Act of 2022 recognizes a number of presumptive health conditions associated with the contaminated water, including:
Emerging evidence also suggests potential links to other conditions, and our attorneys are actively investigating these claims as well.
Filing a Camp Lejeune lawsuit can help you and your family secure the compensation you deserve for the harm caused by the contaminated water. This compensation can cover:
The Camp Lejeune litigation is currently underway in the United States District Court for the Eastern District of North Carolina. Thousands of lawsuits have been filed by veterans, their family members, and civilian workers who were exposed to the contaminated water. The litigation is in the discovery phase, where both sides are gathering evidence and exchanging information.
It is still too early in the litigation to provide precise estimates for individual settlement amounts. However, legal experts anticipate that settlements will vary significantly depending on several factors, including:
Some early settlements have been reached in certain bellwether cases, providing initial insights into potential compensation ranges for specific conditions. As the litigation progresses and more cases are resolved, a clearer picture of potential settlement values will emerge.
In addition to pursuing a traditional lawsuit, the Department of the Navy has established an Elective Option (EO) for certain presumptive conditions. This allows eligible claimants to receive expedited settlement offers based on a tiered system determined by the diagnosed condition and the duration of exposure. While the EO offers a quicker resolution, it may not provide the same level of compensation as a negotiated settlement or a jury verdict in a lawsuit. Our attorneys can help you evaluate whether the EO is the right option for your specific situation.
Our experienced team of environmental and personal injury lawyers is dedicated to fighting for the rights of those harmed by the Camp Lejeune water contamination. We offer:
If you or a loved one were exposed to the contaminated water at Camp Lejeune and have been diagnosed with a presumptive health condition, we encourage you to contact us today for a free and confidential consultation. Our experienced Camp Lejeune lawyers will review your case, explain your legal options, and help you take the first step towards seeking justice and compensation. You can reach us by calling [Phone Number] or filling out our online contact form. Time limits apply to filing claims, so do not delay.
Our lawyers are actively pursuing Roundup lawsuits on behalf of individuals who have been exposed to the herbicide and subsequently developed non-Hodgkin’s lymphoma (NHL) or other related health conditions. The lawsuits allege that Monsanto (now Bayer) failed to adequately warn consumers about the potential cancer risks associated with Roundup exposure.
A second request has been made to the New Jersey Supreme Court to centralize 36 Roundup lawsuits across eight jurisdictions in Atlantic County Superior Court. The plaintiffs argue that consolidation would enhance judicial efficiency, streamline discovery, and prevent inconsistent rulings. Monsanto opposes this, claiming the number of cases doesn’t justify multicounty litigation.
Bayer is lobbying Congress for legal immunity, suggesting it might stop selling Roundup in the U.S. if it doesn’t get it. There are still 67,000 unresolved lawsuits, and Bayer is seeking legislative protection and petitioning the U.S. Supreme Court again.
Bayer is planning to sell more stock to raise billions to cover its financial troubles from pending Roundup lawsuits. This announcement caused a 10% drop in Bayer’s stock, showing investor concern about the company’s future.
No new cases were added to the Roundup MDL last month, keeping the total at 4,414 pending cases.
The Roundup cancer MDL added 14 new cases, bringing the total to 4,414. This is unexpected given the shift towards state courts, where plaintiffs have seen more success recently.
A new study indicates that glyphosate exposure from genetically modified crops is linked to harm to perinatal health in rural U.S. communities, particularly affecting disadvantaged groups. It found increased glyphosate use led to lower birth weights and shorter pregnancies.
RFK, Jr.’s past work in the Roundup litigation was noted during confirmation hearings.
There are ongoing unconfirmed reports about some plaintiffs’ lawyers settling parts of their Roundup lawsuit inventories.
Monsanto is appealing a $175 million verdict in Pennsylvania, arguing jury coercion and evidentiary ruling errors.
The Roundup class action added 27 new cases in December, bringing the total to 4,400 pending lawsuits in the MDL.
A recent study links glyphosate exposure to long-lasting brain damage, with evidence of inflammation and Alzheimer’s-like pathology in mice, raising concerns for Roundup users.
A mistrial was declared in a Chicago Roundup case due to the defense introducing irrelevant and prejudicial information about the plaintiff’s past.
Robert F. Kennedy Jr.’s past criticism of Roundup and involvement in a key case were highlighted, noting his potential influence on future litigation as Secretary of Health and Human Services.
Monsanto won a trial in Philadelphia, despite previous losses in the same jurisdiction.
A Massachusetts state court ruled that federal law preempts failure-to-warn claims, mirroring the 3rd Circuit’s stance.
The Fifth Circuit upheld summary judgment in favor of Monsanto in a skin cancer lawsuit due to statute of limitations issues and unreliable expert testimony.
A jury in Philadelphia awarded $78 million in a Roundup case.
The Third Circuit upheld its decision that federal law preempts state laws requiring cancer warnings on Roundup.
Philadelphia’s sixth Roundup trial began.
A Philadelphia jury cleared Monsanto of liability in a Roundup case.
A Missouri appeals panel upheld a trial court victory for Monsanto.
Monsanto filed motions to exclude testimony from seven plaintiffs’ experts in the MDL.
The 5th Philadelphia Roundup trial began.
The 3rd Circuit ruled that federal pesticide labeling regulations preempt state laws, boosting Bayer’s stock.
An Oregon appellate court reversed a jury verdict, granting the plaintiff a new trial.
A motion for a new trial after a loss in Kline was rejected.
The MDL judge raised concerns about plaintiffs’ firms taking on too many cases.
A House subcommittee voted for a bill that includes FIFRA preemption language, which would protect Bayer.
A Philadelphia Roundup trial was voluntarily dismissed due to statute of limitations issues.
A House subcommittee approved a bill that could limit states’ ability to regulate pesticides.
The trial judge explained the reasoning behind reducing a $2.25 billion verdict to $404 million.
Speculation arose about Bayer potentially using a Texas Two-Step bankruptcy to handle Roundup liabilities.
Bayer is lobbying Congress to pass legislation that would limit Roundup lawsuits.
The New Jersey Supreme Court denied a request to consolidate Roundup cases.
The MDL judge questioned whether some plaintiff firms were taking on too many cases.
A Philadelphia judge reduced a $2.25 billion verdict to $400 million.
Bayer’s CEO described the Roundup lawsuits as an “existential threat” to the company.
The 11th U.S. Circuit Court of Appeals upheld a decision against Bayer.
A new Roundup lawsuit was filed in Delaware by an arborist.
A judge in Missouri reduced a $1.56 billion verdict to $611 million.
The Iowa Senate approved a bill providing legal immunity to agricultural chemical manufacturers.
Roundup, once the world’s most popular weedkiller, faced a downturn following scientific studies linking its active ingredient, glyphosate, to non-Hodgkin’s lymphoma and other cancers, leading to its classification as a possible human carcinogen by international health organizations.
Despite initial denial, Monsanto’s resolve to ignore the link between Roundup and NHL crumbled after the first Roundup trials resulted in substantial verdicts for plaintiffs, including awards of $289 million, $80 million, and a staggering $2 billion, prompting Bayer to allocate $16 billion for settlements.
By March 2022, Bayer reported tentative settlement agreements in approximately 98,000 pending Roundup lawsuits, nearly 80% of the total. As of April 2025, around 67,000 Roundup lawsuits remain open.
Roundup settlements employ a complex point system to categorize cases based on claim strength and injury severity, with factors like cancer type, treatment outcome, age, and earnings capacity determining settlement tiers and payout amounts.
While Bayer continues to settle remaining cases, future liabilities hinge on their U.S. Supreme Court appeal. The long latency period for NHL development means Bayer could face new lawsuits for decades. A proposed global settlement for future claims was rejected. Bayer’s current strategy involves removing glyphosate-based Roundup from retail shelves (starting in 2023) and appealing the *Hardeman* case to the Supreme Court, arguing federal preemption based on EPA findings. Despite losing this argument in the 9th Circuit, Bayer petitioned the Supreme Court. If the appeal fails, Bayer has allocated $4 billion for an administrative process to handle future claims.
What is the average payout for a Roundup lawsuit?
Initial average settlements were between $100,000 and $160,000. While recent billion-dollar verdicts from 2023-2025 raised hopes for higher payouts in subsequent settlements, the actual average for the remaining cases in 2025 is uncertain and likely to have a significant range, potentially influenced by recent adverse rulings for plaintiffs.
How many Roundup lawsuits have been settled?
As of April 2025, it is estimated that over 67,000 Roundup lawsuits are still pending in state and local courts. The exact number of settled cases is not publicly known.
Roundup litigation remains very active in 2025, evolving into one of the largest mass torts in U.S. history. Following initial large verdicts against Monsanto starting in 2018, Bayer allocated over $10 billion by 2020 to settle around 100,000 cases using a tiered compensation system. A controversial plan for future lawsuits was rejected. Juries continued to deliver significant verdicts against Bayer. With another $5.9 billion reserved for future liability (potentially inadequate given recent outcomes), Bayer is again petitioning the Supreme Court, hoping a Third Circuit ruling might prompt intervention. However, a significant shift from the Court’s previous stance is considered unlikely. Settlement talks are ongoing, but a comprehensive global resolution remains elusive, and new claims based on past exposure are expected to continue for years due to the long latency period of related illnesses.
If you need a Roundup lawyer to fight against Monsanto, contact Class Action Lawsuiit today. There is a deadline to file, which is a really big deal. We just saw what was likely to be a great case get dismissed in Philadelphia on the statute of limitation. So contact our lawyers or contact another lawyer today. Don’t wait. You can also reach out to us online.
